HomeHealth

Health

biotech

Base to Base biotech podcast 72: Cell-free DNA bioproduction

Jim Cornall - August 21, 2026

biotech

KTU chemists develop dual-action compounds to fight cancer

Jim Cornall - August 20, 2026

biotech

RSV antiviral drug receives FDA approval for phase II trial

Jim Cornall - August 20, 2026

biotech

Research uncovers new driver of immunotherapy resistance in pancreatic cancer

Jim Cornall - August 19, 2026

automation

Most advanced artificial touch for brain-controlled bionic hand

Jim Cornall - January 17, 2025

Health

Scientists use magnetic nanotech to safely rewarm frozen tissues for transplant

Jim Cornall - September 5, 2024

biotech

New ultrasound technology could transform respiratory disease diagnosis

Jim Cornall - March 28, 2024

Health

Pistoia Alliance enables instant, secure transfer of analytical methods and results data

Jim Cornall - September 12, 2023

Health

Optibrium acquires BioPharmics to expand 3D drug design and visualisation offering

Jim Cornall - September 1, 2023

Health

First Light Fusion and IDOM look to produce cancer-treating medical isotopes from inertial fusion technology

Jim Cornall - August 1, 2023

biotech

10 Lithuanian startups to watch

Jim Cornall - July 30, 2023

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

Base to Base biotech podcast 72: Cell-free DNA bioproduction

Jim Cornall - August 21, 2026 0

This week, we have a conversation about the Flexible Automation for Scalable Health (FLASH) programme, focused on the development of scalable cell-free DNA bioproduction...

KTU chemists develop dual-action compounds to fight cancer

biotech Jim Cornall - August 20, 2026 0

RSV antiviral drug receives FDA approval for phase II trial

biotech Jim Cornall - August 20, 2026 0

Research uncovers new driver of immunotherapy resistance in pancreatic cancer

biotech Jim Cornall - August 19, 2026 0

Pilot project between BioCytics and LIDE Biotech

biotech Jim Cornall - August 19, 2026 0